Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
- DOI
- 10.1186/s12885-021-08085-z
- Published
- 2021 May 24
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-021-08085-z,
title = {Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).},
author = {Grivas P and Loriot Y and Morales-Barrera R and Teo MY and Zakharia Y and Feyerabend S and Vogelzang NJ and Grande E and Adra N and Alva A and Necchi A and Rodriguez-Vida A and Gupta S and Josephs DH and Srinivas S and Wride K and Thomas D and Simmons A and Loehr A and Dusek RL and Nepert D and Chowdhury S},
year = {2021},
journal = {BMC cancer},
doi = {10.1186/s12885-021-08085-z},
url = {https://doi.org/10.1186/s12885-021-08085-z}
}RIS
TY - JOUR TI - Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). AU - Grivas P AU - Loriot Y AU - Morales-Barrera R AU - Teo MY AU - Zakharia Y AU - Feyerabend S AU - Vogelzang NJ AU - Grande E AU - Adra N AU - Alva A AU - Necchi A AU - Rodriguez-Vida A AU - Gupta S AU - Josephs DH AU - Srinivas S AU - Wride K AU - Thomas D AU - Simmons A AU - Loehr A AU - Dusek RL AU - Nepert D AU - Chowdhury S PY - 2021 JO - BMC cancer DO - 10.1186/s12885-021-08085-z UR - https://doi.org/10.1186/s12885-021-08085-z ER -
APA
P, G., Y, L., R, M., MY, T., Y, Z., S, F., NJ, V., E, G., N, A., A, A., A, N., A, R., S, G., DH, J., S, S., K, W., D, T., A, S., A, L., RL, D., D, N., & S, C. (2021). Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).. BMC cancer. https://doi.org/10.1186/s12885-021-08085-z
Source records
- pubmed · retrieved 2026-09-26T18:50:23.414Z